Carcinogenesis, Vol. 21, No. 4, 753-756,
April 2000
© 2000 Oxford University Press
Carcinogenesis |
Promotion of intestinal carcinogenesis by Streptococcus bovis
Université Louis Pasteur, Institut National de la Santé et de la Recherche Médicale, Contrat Jeune Formation 95-09, Institut de Recherche contre les Cancers de l'Appareil Digestif, 1 place de l'hôpital, BP 426, 67091 Strasbourg cedex, France and
1 Institut National de la Santé et de la recherche Médicale, Unité 392, Illkirch-Graffenstaden, France
The involvement of Streptococcus bovis, an member of the human gut flora, in colorectal neoplastic diseases is an object of controversy. The aim of this study was to determine the effects of S.bovis and of antigens extracted from the bacterial cell wall on early preneoplastic changes in the intestinal tract. Adult rats received i.p. injections of azoxymethane (15 mg/kg body weight) once per week for 2 weeks. Fifteen days (week 4) after the last injection of the carcinogen, the rats received, by gavage twice per week during 5 weeks, either S.bovis (1010 bacteria) or wall-extracted antigens (100 µg). One week after the last gavage (week 10), we found that administration of either S.bovis or of antigens from this bacterium promoted the progression of preneoplastic lesions through the increased formation of hyperproliferative aberrant colonic crypts, enhanced the expression of proliferation markers and increased the production of IL-8 in the colonic mucosa. Our study suggests that S.bovis acts as a promoter of early preneoplastic lesions in the colon of rats. The fact that bacterial wall proteins are more potent inducers of neoplastic transformation than the intact bacteria may have important implications in colon cancer prevention.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Dicksved, M. Lindberg, M. Rosenquist, H. Enroth, J. K. Jansson, and L. Engstrand Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls J. Med. Microbiol., April 1, 2009; 58(4): 509 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Burnett-Hartman, P. A. Newcomb, and J. D. Potter Infectious Agents and Colorectal Cancer: A Review of Helicobacter pylori, Streptococcus bovis, JC Virus, and Human Papillomavirus Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 2970 - 2979. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-J. Chen, J.-C. Tsai, T.-C. Chang, W.-C. Hung, S.-P. Tseng, P.-R. Hsueh, and L.-J. Teng PCR-RFLP assay for species and subspecies differentiation of the Streptococcus bovis group based on groESL sequences J. Med. Microbiol., April 1, 2008; 57(4): 432 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Hooper, S.-J. Crean, M. J. Fardy, M. A. O. Lewis, D. A. Spratt, W. G. Wade, and M. J. Wilson A molecular analysis of the bacteria present within oral squamous cell carcinoma J. Med. Microbiol., December 1, 2007; 56(12): 1651 - 1659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Biarc, I. S. Nguyen, A. Pini, F. Gosse, S. Richert, D. Thierse, A. Van Dorsselaer, E. Leize-Wagner, F. Raul, J.-P. Klein, et al. Carcinogenic properties of proteins with pro-inflammatory activity from Streptococcus infantarius (formerly S.bovis) Carcinogenesis, August 1, 2004; 25(8): 1477 - 1484. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Gold, S. Bayar, and R. R. Salem Association of Streptococcus bovis Bacteremia With Colonic Neoplasia and Extracolonic Malignancy Arch Surg, July 1, 2004; 139(7): 760 - 765. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Sasaki, R. Osawa, Y. Nishitani, and R. A. Whiley Development of a Diagnostic PCR Assay Targeting the Mn-Dependent Superoxide Dismutase Gene (sodA) for Identification of Streptococcus gallolyticus J. Clin. Microbiol., March 1, 2004; 42(3): 1360 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Kurtovic, G. N. Jarvis, H. C. Mantovani, and J. B. Russell Ability of Lysozyme and 2-Deoxyglucose To Differentiate Human and Bovine Streptococcus bovis Strains J. Clin. Microbiol., August 1, 2003; 41(8): 3951 - 3954. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. A. Herrero, M. S. Rouse, K. E. Piper, S. A. Alyaseen, J. M. Steckelberg, and R. Patel Reevaluation of Streptococcus bovis Endocarditis Cases from 1975 to 1985 by 16S Ribosomal DNA Sequence Analysis J. Clin. Microbiol., October 1, 2002; 40(10): 3848 - 3850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Gaschott, D. Steinhilber, V. Milovic, and J. Stein Tributyrin, a Stable and Rapidly Absorbed Prodrug of Butyric Acid, Enhances Antiproliferative Effects of Dihydroxycholecalciferol in Human Colon Cancer Cells J. Nutr., June 1, 2001; 131(6): 1839 - 1843. [Abstract] [Full Text]
|
|